Revised Generic Drug Substance Impurities Guidance To Be Issued By FDA
This article was originally published in The Pink Sheet Daily
Executive Summary
Assuming the Office of Chief Counsel does not need to review the guidance, FDA plans to release it “in very short order.” The agency also has plans to replace the existing drug product impurities draft guidance.